| Date | Title | Description |
| 05.06.2026 | Alternative Funding Programs vs. In-Benefit Optimization: Designing a Sustainable Specialty Drug Strategy | Ryan Czado, PharmD, MBA, Chief Pharmacy Officer at RazorMetrics
Specialty medications are expanding what is clinically possible, but not without a price. The affordability gap on these therapies continues to widen, placing sustained pressur... |
| 25.09.2025 | Pharma middlemen propose regulatory changes to avoid Trump administration rules, Bloomberg News reports | Pharma middlemen propose regulatory changes to avoid Trump administration rules, Bloomberg News reports
By ReutersSeptember 24, 20259:29 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Bottles o... |
| 04.08.2025 | AvevoRx Expands Managed Care Partnerships, Securing Access to More Than 18 Million Additional Covered Lives | AvevoRx is an independent provider of specialty infusion pharmacy and infusion care services
Newly executed contracts with regional Blues plans and forward-thinking PBMs reflect AvevoRx's strategic investment in patient-centered managed car... |
| 06.03.2025 | Starbucks Shakes Up Leadership with New CFO Amidst Sales Struggles | Starbucks is brewing a storm in its executive suite. The coffee giant has announced the appointment of Cathy Smith as its new Chief Financial Officer (CFO), a move that signals a significant shift in leadership. Smith, who previously held t... |
| 04.03.2025 | Starbucks poaches Nordstrom CFO as executive shake-up continues | Nordstrom Chief Financial Officer Cathy Smith will join Starbucks, replacing its current CFO Rachel Ruggeri.
Starbucks CEO Brian Niccol has shaken up the leadership team since joining the coffee chain in September.
Smith is expected to star... |
| 17.12.2024 | Insurer stocks fall after Trump says 'we're going to knock out the middleman' | Insurer stocks fall after Trump says 'we're going to knock out the middleman'
By ReutersDecember 16, 20249:24 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 U.S. flag and medicines ... |
| 03.10.2024 | Sweet Revolution: Wild Thingz Aims to Change the Confectionery Game | In a world where health-conscious choices are becoming the norm, a new player is stepping into the candy arena. Fliss Newland, a former executive at Mondelez, has launched Wild Thingz, an organic vegan confectionery brand that promises to s... |
| 01.10.2024 | Social support becomes lifeline for health amid financial strain | Study reveals health and vitality is closely linked to mental, social, and physical health.
Financial well-being remains the weakest aspect of well-being, with finance-related concerns as top stressors
High vitality leads to better health m... |
| 20.09.2024 | US FTC sues drug 'gatekeepers' over high insulin prices | Healthcare & PharmaceuticalsHealth
Health Insurance
Healthcare Providers
Litigation
US FTC sues drug 'gatekeepers' over high insulin prices
By Jody Godoy and Ahmed AbouleneinSeptember 20, 20248:06 PM UTCUpdated ago
Text
Small Text
Mediu... |
| 04.09.2024 | Health | Independent pharmacies say they’re being squeezed by shadowy middlemen tied to big health chains | The disappearance of independent pharmacies could limit consumer choice and health care access — especially in low-income or rural communities.
On Oakland’s Telegraph Avenue, Selam Pharmacy owner Michael Gebru called PBMs “a big black box.”... |
| 30.08.2024 | /DISREGARD RELEASE: Celltrion USA/ | We are advised by Celltrion USA that journalists and other readers should disregard the news release, Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-... |
| 29.08.2024 | A New Era in Treatment: Celltrion USA's ZYMFENTRA® Partnership with Cigna and Express Scripts | In the ever-evolving landscape of healthcare, partnerships can pave the way for innovation and accessibility. Celltrion USA has recently made headlines by teaming up with Cigna Healthcare and Express Scripts. This collaboration aims to broa... |
| 29.08.2024 | Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit form... | JERSEY CITY, N.J., Aug. 29, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scripts, the pharmacy benefits services busine... |
| 28.08.2024 | Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit form... | JERSEY CITY, N.J., Aug. 28, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scripts, the pharmacy benefits services busine... |
| 23.07.2024 | EmpiRx Health Strongly Supports Growing Congressional and Regulatory Scrutiny of the Business Practices of the Largest PBM Companies | House Oversight Committee Holds Hearing Today to Examine the "Anticompetitive"
Practices of the Largest PBM Companies; FTC Issues Scathing New Report on PBMs
MONTVALE, N.J., July 23, 2024 /PRNewswire/ -- EmpiRx Health, the leading... |
| 10.07.2024 | Spotlight on PBMs gets harsher | figcaption>span]:font-sans" data-chromatic="ignore">
The drumbeat for PBM reforms is intensifying, highlighted by a scathing Federal Trade Commission report on the industry's business practices and a coming House Oversi... |
| 14.06.2024 | Health | Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say | “We cannot interfere in the negotiations that occur between the plans and pharmacy benefits managers,” Meena Seshamani, director of the Center for Medicare, said at a conference on June 7. “We cannot tell a plan how much to pay a pharmacy o... |
| 29.04.2024 | Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors | BOSTON, April 29, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent di... |
| 28.04.2024 | Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA™ | JERSEY CITY, N.J., April 28, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans coverin... |
| 14.04.2024 | FTC chair Lina Khan on playing "anti-monopoly" | Monopoly is the game where you bankrupt competitors, buying up the board and charging sky-high prices. But in Washington, Lina Khan is playing a different game: Anti-Monopoly. "The experience is not quite akin to playing a board game, ... |
| 17.03.2024 | Should the DOJ Break Up UnitedHealth Group? | Consider this: Aside from being the largest health insurance player in the country, UnitedHealth Group also
Employs or contracts with thousands of physicians
Owns OptumRx, one of the top three largest pharmacy benefit managers
Has spent mor... |
| 13.03.2024 | Business | Health insurance CEOs rake in millions. Here’s the top 10 list. | Health insurance premiums keep rising and many employees carry high-deductible plans that mean bills of $100 or more for a visit to the doctor.
Meanwhile, the CEOs of the top 10 health insurance companies were paid between $13 million and $... |
| 21.11.2023 | Filling 12-month prescriptions is one practical way to help the pharmacist crisis | Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to ge... |
| 12.10.2023 | Digital health tech is about making healthcare more humane | Telehealth and online pharmacies, generative AI for patient records, and supportive games
Whether it’s skipping the line at your pharmacy, getting 24/7 access to virtual support, recapping what the doctor said during a visit, or scoring gam... |
| 01.04.2023 | Uber Now Offering Same-Day Prescription Drug Delivery via Healthcare Platform | Trisha Kae Andrada, Tech Times 01 April 2023, 08:04 am
(Photo : by DENIS CHARLET/AFP via Getty Images)
To further its goal of expanding people's access to healthcare, Uber Health said this week that it will begin offering same-day delivery ... |
| 31.03.2023 | Uber Hits Another Milestone In Healthcare, Launching Same-Day Prescription Delivery | Earlier this week, Uber Health announced yet another milestone in its mission to improve healthcare access: same day prescription delivery. |
| 27.03.2023 | Ohio attorney general accuses pharmacy benefit managers of drug price fixing | The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers of fixing prices for various medicines, the latest effort to scrutinize the controversial companies that occupy a crucial role in pharmaceuti... |
| 06.07.2022 | Changes in Technology are Moving Medicine into the Post-COVID Era | David Thompson, Tech Times 06 July 2022, 11:07 am
(Photo : Senpex | BetterWorldRx)
Among the changes that the COVID-19 pandemic brought to the world of healthcare is an expectation for greater accessibility. Because of their experiences dur... |
| 24.01.2022 | RecoveryOne, Cigna Offers Virtual Physical Therapy for Medicare Advantage Customers | What You Should Know:
– RecoveryOne, a digital health innovator dedicated to improving health outcomes for recovery from musculoskeletal (MSK) injuries of all types and reducing costs, announced an expansion of its partnership with Cigna to... |
| 27.01.2021 | Miami Ad Agency & PR Firm Expands Executive Leadership Team Amidst Pandemic | Jeff Siwak, Director of Client Accounts at The Weinbach Group As we help these companies navigate this new era, we feel confident having Jeff guide them.
MIAMI (PRWEB) January 27, 2021
The Weinbach Group, a nationally recognized healthcare ... |
| 12.08.2020 | 2 ways to help support your team’s mental health | Image: Prostock Studio, Getty Images/iStockPhoto Must-read CXO coverage
Power BI vs. Tableau
ATS: The best applicant tracking systems
Apple, Microsoft top list of most ethical tech companies
How to hire an IoT Architect (TechRepublic Premiu... |
| 10.06.2020 | How to Save Money on Prescriptions if You Lost Coverage | (StatePoint) Many Americans are feeling the effects of job loss and furloughs as a result of the COVID-19 pandemic. For people with a chronic condition, loss of insurance coverage can create additional stress during this uncertain time. How... |
| 17.04.2020 | After declining for years, anxiety and insomnia prescriptions start to climb | While prescriptions for antidepressants have climbed in the U.S. in recent years, those for anxiety and insomnia have fallen, a new report shows — but the numbers also suggest the coronavirus pandemic could fuel a rise in the use of medicat... |
| 21.01.2020 | Digital health, digital therapeutics, digital medicines – what’s in a name? | To differentiate themselves from the health and wellness pack, digital therapeutics have attempted to back claims that they can prevent or treat certain conditions with clinical evidence. There’s still a lot of wiggle room in that definitio... |
| 12.12.2019 | Express Scripts Launches First Digital Health Formulary for Apps & Devices | – Express Scripts launches its first digital health formulary that will allow employers and health plans to effectively manage a fast-growing segment of healthcare while improving access for patients.
– Starting in January 2020, Express Scr... |
| 12.11.2019 | Should employers take a chance on little-known Embarc to pay for gene therapy? | The promise of curing deadly diseases by administering a one-time therapy that rewrites a patient’s genetic code is no longer the stuff of science fiction. Yet this innovation comes with a steep price tag.
Zolgensma, approved for spinal mus... |
| 08.11.2019 | Research: October Health IT M&A Activity, Public Company Performance | – Healthcare Growth Partners (HGP) summary of Health IT/digital health merger & acquisition (M&A) activity, and public company performance during the month of October 2019
During the month of October, Health IT continued its evoluti... |
| 17.10.2019 | Cigna-owned Express Scripts buys Seattle-area health tech startup Verity Solutions | Verity CEO George Puckett. (Verity Photo)
Verity Solutions, a Kirkland, Wash.-based startup that sells drug pricing software, was snapped up by Express Scripts, a large pharmacy benefit manager that is part of health insurance giant Cigna. ... |
| 08.09.2019 | Cigna creates new program to pay for high-price gene therapies | According to an accompanying infographic, the program involves plans paying monthly for each member to enter the gene therapy network. Physicians then submit a prior authorization, while patients receive it at no out-of-pocket cost, and the... |
| 06.06.2019 | AIDS groups criticize Express Scripts for excluding several HIV medicines | A recent decision by one of the largest pharmacy benefit managers in the U.S. to exclude several HIV medicines from its list of drugs eligible for insurance coverage has angered AIDS advocacy groups, which argue the move may harm patients.
... |
| 25.03.2019 | Humalog's list price may have gone up, but Lilly says it got paid less per sale in 2018 versus 2014 | As scrutiny into insulin pricing in the United States intensifies, Lilly is laying out the groundwork for its defense ahead of a third Congressional hearing on soaring drug prices next month in which the middlemen — phar... |
| 13.03.2019 | US lawmakers now want to hear from the middlemen PBMs to unpack their role in drug pricing | The US Senate Finance Committee is upping the ante on the issue of drug pricing with yet another hearing — this time with pharmacy benefit managers, the middlemen that negotiate rebates with drugmakers in exchange fo... |
| 07.03.2019 | FDA pins another 'breakthrough' badge on AbbVie's venetoclax; Express Scripts bats back at drugmakers on pricing | → AbbVie $ABBV has collected a fifth breakthrough therapy designation for venetoclax as it climbs the blockbuster mountain with the apoptosis drug. The latest endorsement from the FDA covers venetoclax’s first-line us... |
| 07.02.2019 | As magnitude and frequency of drug price hikes thaw, Express Scripts reports lowest increase in spending by commercial plans in 25 years | In an era where drugmakers and prescription drug managers (PBMs) point fingers at each other when it comes to justifying the reasons behind rising drug prices — the largest US PBM, Express Scripts, on Wednesday released a re... |
| 22.08.2018 | CVS announcement of cost-effective benchmarks puts ICER in the spotlight | Last week’s announcement by CVS Health, which operates one of the country’s largest pharmacy benefit managers, is a harbinger of what may lie ahead for drug pricing and access in the United States.
In what it called an effort to nudge drug ... |
| 07.08.2018 | Express Scripts to drop dozens more drugs from its formulary next year | As the cost of prescription drugs generates increased controversy, Express Scripts (ESRX), the nation’s largest pharmacy benefit manager, will be removing still more medicines from its list of drugs covered by insurance, known as formularie... |
| 11.05.2018 | The Trump administration has a little-known practice in the pharma industry in its crosshairs | Chip Somodevilla/Getty Images
Donald Trump.
Advertisement
A pricing practice the pharmaceutical supply chain relies is one of the targets of President Donald J. Trump's speech Friday about ways to lower drug prices.
Rebates, which are negot... |
| 08.03.2018 | HIMSS18 Day 3 Coverage Highlights & Summary
Philips selected by Partners HealthCare and Triad HealthCare Network to help reduce costs of at-risk patients
Mayo Clinic’s clinical trial matching pr... | Health Insurer Cigna to Acquire Express Scripts for $67 Billion
Cigna Corporation has acquired Express Scripts Holding Company in a cash and stock transaction valued at approximately $67 billion, including Cigna’s assumption of approximatel... |
| 08.02.2018 | 'Perfect Storm' Driving $10bn Of Deals In Healthtech, Reveals Hampleton Partners' Latest M&A Report | Wearables, connected systems, mission-critical healthcare software and new entrants into the sector are driving the future of Healthtech M&A
London, 8 February 2018 - The latest Healthtech M&A Report from international technology me... |
| 02.12.2017 | The FDA just approved the first direct competitor to a $6.7-billion-dollar cancer drug | Reuters/Luke MacGregor
A pharmacologist holds a phial of concentrated herceptin in London June 9, 2006.
Advertisement
The FDA on Friday approved a version of Herceptin, a blockbuster cancer drug used to treat breast and stomach cancer.
The ... |
| 27.11.2017 | Avista Capital Partners to Acquire United BioSource | St. Louis and New York, November 27, 2017 – Express Scripts (NASDAQ: ESRX) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly... |
| 16.11.2017 | Express Scripts inks deal with Propeller Health to provide members access to inhaler monitoring tools | Pharmacy benefits manager Express Scripts inked a deal to give access to Propeller Health‘s inhaler monitoring tools for asthma and COPD to its members. The news, which CNBC reported last night, comes at a time when pharmacy benefit manager... |
| 10.10.2017 | As Express Scripts pays $3.6B for eviCore Healthcare, did Amazon make the PBM blink? | Pharmacy benefit managers, among other things, negotiate prices of covered drugs with pharma companies, use financial incentives to steer patients to lower-cost generics and manage high-cost specialty medications.
The deal could be a way fo... |
| 31.08.2017 | A $475,000 price tag for a new cancer drug: crazy or meh? | Forget McGregor-Mayweather. The biotech world has been waiting for months to hear about Novartis’s pricing decision for Kymriah, its just-approved CAR-T therapy for cancer. That interest turned into anxiety days earlier when Gilead announce... |
| 25.08.2017 | Why do so many millennials struggle to take their pills consistently? | Here’s a generalization about millennials you may not have heard before: They struggle mightily to take their daily pills as prescribed.
Commercially insured young adults are significantly less likely than their older counterparts to be adh... |
| 15.03.2017 | Cancer patients skipping medicines or delaying treatment due to high drug prices | John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger.
The doctor recommended a drug called Alecensa, which sells for more than $159,000 a year. Medic... |
| 14.10.2016 | The insulin market is heading for a shakeup. But patients may not benefit | The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of a shakeup.
The first “follow-on” insulin for diabetics, similar to a generic medication for synthetic drugs, will hit the market in December. It’s... |
| 18.07.2016 | Medicare fraud investigators wary of soaring compounded drug prices | The spending jump, along with a sharp increase in the number of patients getting the compounded drugs “may indicate an emerging fraud trend,” said Miriam Anderson, who helped oversee a June report on the Medicare spending by the inspector g... |
| 05.04.2016 | Pharmalot, Pharmalittle: Rising drug prices cost workers’ compensation programs | Good morning, everyone, and how are you today? A bright, shiny sun is enveloping the Pharmalot campus, although it is not yet enough to counteract the bitter cold. In fact, our short person, who is under the weather, is staying home to avoi... |
| 29.12.2015 | Midwest Report: All of the Region's Major Tech Fundings, M&As, and IPOs in December | While we're primarily focused on Chicago's innovation economy, we also have our eyes on all of the startup and tech activity happening throughout the entire Midwest. Here are the major tech fundings, acquisitions, mergers, moves and IPOs th... |
| 24.06.2015 | Will other states follow California and cap prices on expensive drugs? | Mikkel Lawrence, a retired middle school teacher in California, is the kind of patient lawmakers had in mind when they designed the new policy.
Lawrence has hepatitis C, a virus that can damage the liver. Most people who have the virus don’... |
| 14.04.2015 | Online Pharmacy Startup PillPack Pushes Drug Delivery To California | PillPack, the online medication delivery service out of New Hampshire, is now available in California. This is the 47th state in the U.S. to receive the green light to allow consumers to order prescriptions, over-the-counter medications and... |
| 06.03.2015 | The biosimilar transition moves forward with FDA approval of the drug Zarxio | “The F.D.A. approval of Zarxio marks a significant milestone for the United States health care system,” said Carol Lynch, Global Head of Biopharmaceuticals and Oncology Injectables at Sandoz, according to The New York Times.
The Times spell... |
| 06.02.2013 | If nonadherence is a “health condition”, use big data as preventive screening tool | But pharmacy benefits management company Express Scripts, like RxAnte, is taking a different approach to tackling this problem. The company wants to be able to predict who will become noncompliant in a six- to 12-month period and then tailo... |
| 28.09.2012 | Can data analysis predict who will adhere to medications, which interventions would help? | The startup isn’t trying to create interventions for medication adherence; rather, it’s trying to help clinicians, payers and pharmaceutical companies know which patients will be non-compliant, and which interventions would be most likely t... |
| 01.12.2009 | Express Scripts closes $4.7B deal to buy WellPoint pharmacy unit | - |
| 17.04.2009 | MedCity morning read, Friday, April 17 | In another measure of rising prices, Express Scripts Inc., one of the nation’s largest pharmacy-benefits managers, said it saw prices rise more than 10 percent to 15 percent between the 2008 first quarter and the just-ended quarter, the Jou... |
| 01.05.2007 | Roundup: No-nukes cancer treatment, E. coli vaccines, ovarian-tissue banking, more | No nukes in lymphoma treatment — Two innovative biotech drugs that target tumor cells for destruction by tiny radioactive particles are struggling in the marketplace, in part because cancer doctors are simply too specialized to make proper ... |
| - | MedCity morning read, Friday, April 17 | Hospitals and drug companies raised prices to bolster earnings in the first quarter even as government and private insurers struggled to reign in runaway health care costs, according to an analysis done by the Wall Street Journal (subscri... |
| - | Digital health, digital therapeutics, digital medicines – what’s in a name? | As the digital health industry gains ground, companies have bandied about all sorts of terminology. Some sell digital medicines. Others sell digital therapeutics. One company that went public last year describes itself as an “applied health... |
| - | Will other states follow California and cap prices on expensive drugs? | Expensive specialty medicines used to treat cancer and chronic illnesses have forced some very ill Americans to choose between getting proper treatment and paying their rent.
To ease the financial burden, the California agency that governs ... |
| - | If nonadherence is a “health condition”, use big data as preventive screening tool | Many companies are taking a crack at the intractable and expensive problem of medication nonadherence. The question is how to get people to take their prescription medications regularly so there is no interruption to their care regimen.
Not... |
| - | As Express Scripts pays $3.6B for eviCore Healthcare, did Amazon make the PBM blink? | Express Scripts plans to shell out $3.6 billion to buy eviCore Healthcare from a group of investors. It’s a deal that will see the company break free from the prescription drug benefits manager and expand into the wider realm of medical ben... |
| - | Express Scripts inks deal with Propeller Health to provide members access to inhaler monitoring tools | Pharmacy benefits manager Express Scripts inked a deal to give access to Propeller Health‘s inhaler monitoring tools for asthma and COPD to its members. The news, which CNBC reported last night, comes at a time when pharmacy benefit manager... |
| - | Cigna creates new program to pay for high-price gene therapies | A worker at Spark Therapeutics’ manufacturing plant
One of the biggest questions about high-priced gene and cell therapies is how to pay for them, particularly as their list prices have climbed from the hundreds of thousands of dollars into... |
| - | How to Save Money on Prescriptions if You Lost Coverage | (StatePoint) Many Americans are feeling the effects of job loss and furloughs as a result of the COVID-19 pandemic. For people with a chronic condition, loss of insurance coverage can create additional stress during this uncertain time. How... |
| - | Can data analysis predict who will adhere to medications, which interventions would help? | It’s one of healthcare’s great mysteries: How the heck do we get patients to take their medicines?
We’re offering them cash rewards, giving them high-tech pill dispensers and sending them mobile reminders. Soon we’ll even be feeding them sm... |
| - | The biosimilar transition moves forward with FDA approval of the drug Zarxio | On Friday, the Food and Drug Administration approved the first biosimilar, marking an initial big step foward in changing the climate of the drug market in the United States.
Time to save some money.
Zarxio, produced by Sandoz, Inc. – a div... |
| - | Senators question Pfizer Lipitor deals, Ranbaxy gets FDA approval for generic version | Three U.S. senators are raising questions with Pfizer (NYSE:PFE) over its deal making for its mega-blockbuster cholesterol drug Lipitor as generic drug makers step up to market the drug, most recently Ranbaxy Laboratories, an India-based ge... |
| - | Medicare fraud investigators wary of soaring compounded drug prices | Government spending on compounded drugs that are handmade by retail pharmacists has skyrocketed, drawing the attention of federal investigators who are raising fraud and overbilling concerns.
Spending on these medications in Medicare’s Part... |
